The most important thing to keep in mind when you look at Walgreens today is -- unfortunately-- its weak business performance ...

Walgreens Boots Alliance should be a private company before the end of the year after jumping the potential hurdle of a ...

Walgreens' stock price isn't going anywhere fast. Walgreens' weak business performance is not a new phenomenon. It has been struggling for years. At first, it was more about sluggish growth.

For the fiscal third quarter ended May 31, Walgreens posted adjusted earnings of 38 cents a share, topping the 25 cents analysts had expected. Sales of $39 billion surpassed the $37 billion Wall ...

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement rates for prescription drugs.

In the long term, WBA stock has surged 21.7% on a YTD basis, outperforming the Nasdaq’s 1.7% increase. However, shares of WBA declined 28.9% over the past 52 weeks, underperforming Nasdaq’s 11 ...

Walgreens Boots Alliance (WBA) closed at $11.16 in the latest trading session, marking a +0.95% move from the prior day. The stock outperformed the S&P 500, which registered a daily gain of 0.58%.

Walgreens Boots Alliance's fiscal third-quarter results came in above FactSet consensus estimates. Total revenue of $39 billion was up 7.2% year over year, and adjusted earnings per share declined ...

Walgreens Boots Alliance (NASDAQ: WBA) is one of the largest pharmacy retailers in the United States. While there's a potential turnaround opportunity for the business in the years ahead, that ...

In the latest market close, Walgreens Boots Alliance (WBA) reached $11.20, with a -0.44% movement compared to the previous day. The stock fell short of the S&P 500, which registered a gain of 0.41 ...